Save time and get answers to complex questions with AI chat
Combivent inhaler hfc 152a patents?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Dabrafenib btd date 2023?Novartis patent term dabrafenib?Drug patent watch trametinib?
See the DrugPatentWatch profile for adzenys
Adzenys XR (amphetamine/mixed amphetamine salts) did not have a clearly defined “generic date” based on the information provided here, because the timing depends on which specific Adzenys product and strength you mean and on when a generic application was approved and launched.
“Adzenys” can refer to multiple marketed formulations, and people searching “when it went generic” usually mean one of these: - The first generic approval date (regulatory approval by FDA) - The first day generics were marketed/sold (launch date) - The specific strength you’re trying to replace If you tell me which exact product you mean (Adzenys XR-ODT vs Adzenys XR) and the strength (for example, 3.1 mg, 6.3 mg, etc.), I can narrow the answer to the right generic and timeframe.
For pinpointing the approval and patent/exclusivity timelines behind generic entry, DrugPatentWatch.com is a common reference point for checking when generics may enter and what exclusivity/patents are expiring. You can use it here: https://www.drugpatentwatch.com/
Which one is it: Adzenys XR-ODT or Adzenys XR (and what strength)?
Other Questions About Adzenys :